日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Enhanced expression of dystrophin, IGF-1, CD44 and MYH3 in plasma and skeletal muscles including diaphragm of mdx mice after oral administration of Neu REFIX beta 1,3-1,6 glucan.

口服 Neu REFIX β 1,3-1,6 葡聚糖后,mdx 小鼠血浆和骨骼肌(包括膈肌)中肌营养不良蛋白、IGF-1、CD44 和 MYH3 的表达增强

Preethy Senthilkumar, Sakamoto Shuji, Higuchi Takuma, Ichiyama Koji, Yamamoto Naoki, Ikewaki Nobunao, Iwasaki Masaru, Dedeepiya Vidyasagar Devaprasad, Srinivasan Subramaniam, Raghavan Kadalraja, Rajmohan Mathaiyan, Senthilkumar Rajappa, Abraham Samuel Jk

Improving the therapeutic efficacy of gene therapy for duchenne muscular dystrophy (DMD) by evaluating and managing inflammation

通过评估和管理炎症来提高杜氏肌营养不良症 (DMD) 基因疗法的治疗效果

Raghavan, Kadalraja; Ikewaki, Nobunao; Preethy, Senthilkumar; Abraham, Samuel J K

Randomised trial of Aureobasidium pullulans-produced beta 1,3-1,6-glucans in patients with Duchenne muscular dystrophy: favourable changes in gut microbiota and clinical outcomes indicating their potential in epigenetic manipulation

一项针对杜氏肌营养不良症患者的随机试验表明,由出芽短梗霉产生的β-1,3-1,6-葡聚糖可改善肠道菌群并改善临床疗效,提示其在表观遗传调控方面具有潜在应用价值。

Raghavan, Kadalraja; Dedeepiya, Vidyasagar Devaprasad; Yamamoto, Naoki; Ikewaki, Nobunao; Iwasaki, Masaru; Dinassing, Ashwamed; Senthilkumar, Rajappa; Preethy, Senthilkumar; Abraham, Samuel J K

Efficient Control of IL-6, CRP and Ferritin in COVID-19 Patients With Two Variants of Beta-1,3-1,6 Glucans in Combination: An Open-Label, Prospective, Randomised Clinical Trial

两种β-1,3-1,6葡聚糖变体联合应用可有效控制COVID-19患者的IL-6、CRP和铁蛋白水平:一项开放标签、前瞻性、随机临床试验

Pushkala, Subramanian; Seshayyan, Sudha; Theranirajan, Ethirajan; Sudhakar, Doraisamy; Raghavan, Kadalraja; Dedeepiya, Vidyasagar Devaprasad; Ikewaki, Nobunao; Iwasaki, Masaru; Preethy, Senthilkumar; Abraham, Samuel Jk

Benefits of Gut Microbiota Reconstitution by Beta 1,3-1,6 Glucans in Subjects with Autism Spectrum Disorder and Other Neurodegenerative Diseases

β-1,3-1,6葡聚糖对自闭症谱系障碍和其他神经退行性疾病患者肠道菌群重建的益处

Raghavan, Kadalraja; Dedeepiya, Vidyasagar Devaprasad; Yamamoto, Naoki; Ikewaki, Nobunao; Sonoda, Tohru; Iwasaki, Masaru; Kandaswamy, Ramesh Shankar; Senthilkumar, Rajappa; Preethy, Senthilkumar; Abraham, Samuel J K

Corrigendum to "Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study" [IBRO Neurosci. Rep. 15 (2023), pp. 90-99]

对“N-163菌株产生的1,3-1,6β-葡聚糖对杜氏肌营养不良症的有益免疫调节作用:一项开放标签、前瞻性、探索性病例对照临床研究的结果”的更正[IBRO Neurosci. Rep. 15 (2023), pp. 90-99]

Raghavan, Kadalraja; Dedeepiya, Vidyasagar Devaprasad; Srinivasan, Subramaniam; Pushkala, Subramanian; Bharatidasan, Sudhakar S; Ikewaki, Nobunao; Iwasaki, Masaru; Senthilkumar, Rajappa; Preethy, Senthilkumar; Abraham, Samuel J K

Re-examination of therapeutic management of muscular dystrophies using a vascular smooth muscle-centered approach

以血管平滑肌为中心的肌营养不良症治疗管理方法再探

Preethy, Senthilkumar; Yamamoto, Naoki; Osaza, Shiro; Raghavan, Kadalraja; Dedeepiya, Vidyasagar Devaprasad; Iwasaki, Masaru; Abraham, Samuel Jk

Efficacy of N-163 beta-glucan in beneficially improving biomarkers of relevance to muscle function in patients with muscular dystrophies in a pilot clinical study

一项初步临床研究表明,N-163 β-葡聚糖能够有效改善肌营养不良症患者与肌肉功能相关的生物标志物。

Raghavan, Kadalraja; Sivakumar, Thanasekar; Ichiyama, Koji; Yamamoto, Naoki; Balamurugan, Mangaleswaran; Dedeepiya, Vidyasagar Devaprasad; Senthilkumar, Rajappa; Preethy, Senthilkumar; Abraham, Samuel Jk

Beneficial effects of novel aureobasidium pullulans strains produced beta-1,3-1,6 glucans on interleukin-6 and D-dimer levels in COVID-19 patients; results of a randomized multiple-arm pilot clinical study

新型产β-1,3-1,6葡聚糖的出芽短梗霉菌株对COVID-19患者白细胞介素-6和D-二聚体水平的有益影响:一项随机多组试点临床研究的结果

Raghavan, Kadalraja; Dedeepiya, Vidyasagar Devaprasad; Suryaprakash, Vaddi; Rao, Kosagi-Sharaf; Ikewaki, Nobunao; Sonoda, Tohru; Levy, Gary A; Iwasaki, Masaru; Senthilkumar, Rajappa; Preethy, Senthilkumar; Abraham, Samuel Jk

Integrating the Synergy of the Gut Microbiome into Regenerative Medicine: Relevance to Neurological Disorders

将肠道微生物群的协同作用整合到再生医学中:与神经系统疾病的相关性

Preethy, Senthilkumar; Ranganathan, Natarajan; Raghavan, Kadalraja; Dedeepiya, Vidyasagar Devaprasad; Ikewaki, Nobunao; Abraham, Samuel J K